ArticleFrontiers in endocrinology2022

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD.

Jiajia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.